Quartz Partners
BIIB icon

Quartz Partners’s Biogen BIIB Stock Holding History

Quartz Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$268K Buy
+1,188
New +$252K 0.08% 177

Other funds holding BIIB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Quartz Partners's BIIB Position: Q3 2026 in Review

Quartz Partners opened a new position in Biogen (BIIB) in Q3 2026: 1,188 shares worth $268K. The stake represents 0.08% of the portfolio and ranks #177 among its holdings.

532 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Quartz Partners held 1,188 shares of Biogen worth $268K as of Q3 2026.
  • Biogen was a new Quartz Partners position in Q3 2026.
  • Biogen made up 0.08% of Quartz Partners's portfolio in Q3 2026, its #177 holding.
  • 532 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Quartz Partners's 13F filing for Q3 2026, filed 3 Nov 2026.